STRUCTURE-ACTIVITY-RELATIONSHIPS OF DOPAMINE AGONISTS

[31] DESIGN OF AGENTS FOR STIMULATION OF NEOSTRIATAL DOPAMINERGIC MECHANISMS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (10) : 753 - 762

[32] DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 337 - 342

[33] DIFFERENTIAL ACTIVATION BY SOME 2-AMINOTETRALIN DERIVATIVES OF RECEPTOR MECHANISMS IN NUCLEUS ACCUMBENS OF RAT WHICH MEDIATE HYPERACTIVITY AND STEREOTYPED BITING [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (03) : 307 - 319

[34] ON THE PREFERRED ROTAMERIC CONFORMATION FOR DOPAMINE AGONIST ACTION - AN ILLUSORY QUEST [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (04) : 246 - 254

[35] STUDIES ON DOPAMINE AGONIST PROPERTIES OF 8-AMINO-2-METHYL-4-(3,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE, A DERIVATIVE OF NOMIFENSINE [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (08) : 514 - 516

[36] TOPOGRAPHICAL MODEL OF THE RENAL VASCULAR DOPAMINE RECEPTOR [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (09) : 1059 - 1061

[37] CONFORMATIONAL ANALOGS OF DOPAMINE - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF (E)-2-(3,4-DIHYDROXYPHENYL)CYCLOPROPYLAMINE AND (Z)-2-(3,4-DIHYDROXYPHENYL)CYCLOPROPYLAMINE HYDROCHLORIDES [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (08) : 907 - 911

[38] ACTIVITY OF 2 NEW POTENT DOPAMINERGIC AGONISTS AT THE STRIATAL AND ANTERIOR-PITUITARY LEVELS [J]. NEUROPHARMACOLOGY, 1980, 19 (04) : 379 - 386

[39] EFFECT OF NON-CATECHOLIC 2-AMINOTETRALIN DERIVATIVES ON DOPAMINE METABOLISM IN THE RAT STRIATUM [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 313 (03) : 213 - 219

[40] FIRNAU G, 1981, MOL PHARMACOL, V19, P130

[31] DESIGN OF AGENTS FOR STIMULATION OF NEOSTRIATAL DOPAMINERGIC MECHANISMS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (10) : 753 - 762

[32] DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 337 - 342

[33] DIFFERENTIAL ACTIVATION BY SOME 2-AMINOTETRALIN DERIVATIVES OF RECEPTOR MECHANISMS IN NUCLEUS ACCUMBENS OF RAT WHICH MEDIATE HYPERACTIVITY AND STEREOTYPED BITING [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (03) : 307 - 319

[34] ON THE PREFERRED ROTAMERIC CONFORMATION FOR DOPAMINE AGONIST ACTION - AN ILLUSORY QUEST [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (04) : 246 - 254

[35] STUDIES ON DOPAMINE AGONIST PROPERTIES OF 8-AMINO-2-METHYL-4-(3,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE, A DERIVATIVE OF NOMIFENSINE [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (08) : 514 - 516

[36] TOPOGRAPHICAL MODEL OF THE RENAL VASCULAR DOPAMINE RECEPTOR [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (09) : 1059 - 1061

[37] CONFORMATIONAL ANALOGS OF DOPAMINE - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF (E)-2-(3,4-DIHYDROXYPHENYL)CYCLOPROPYLAMINE AND (Z)-2-(3,4-DIHYDROXYPHENYL)CYCLOPROPYLAMINE HYDROCHLORIDES [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (08) : 907 - 911

[38] ACTIVITY OF 2 NEW POTENT DOPAMINERGIC AGONISTS AT THE STRIATAL AND ANTERIOR-PITUITARY LEVELS [J]. NEUROPHARMACOLOGY, 1980, 19 (04) : 379 - 386

[39] EFFECT OF NON-CATECHOLIC 2-AMINOTETRALIN DERIVATIVES ON DOPAMINE METABOLISM IN THE RAT STRIATUM [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 313 (03) : 213 - 219

[40] FIRNAU G, 1981, MOL PHARMACOL, V19, P130